HSCSW
HeartSciences Inc.Warrants of HeartSciences Inc. · HSCS stock page →
—
Market cap
$222.8K
Nano cap
1 year
−3.1%
from $3.24 · Oct 27
30 days
−29.1%
from $4.43
52-week range
$1.67–5.20
−40% from high · low May 29
Avg volume 20D
230.8K
Oct 5 spike 2.14M
Short interest
1.1K
≈0.0% of shares · −10.3%
Days to cover
1.0
at average volume
New fund stakes
0
Q1 2026 13F · 0 exits
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Jul 31 Short interest jumps 29.0% to 2.1K
- X Sep 15 Short interest falls 35.1% to 1.3K
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q1 2026: 1 added (0 new), 0 trimmed or exited.
- Short sellersSTEADY
Short interest −10.3% to 1.1K shares. 1.0 days to cover, ≈0.0% of shares.
- TrendDOWNTREND
10% below its 50-day average.
Who's buying
13F· Q1 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $71.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 15, 2026
Earnings
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with…
Aug 12, 2026
Listing
Listing Status: HSCSW — Deficient (was Normal)
HeartSciences Inc. - Warrant | Nasdaq Financial Status Indicator N → D
Jul 29, 2026
Earnings
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company’s…
Jul 23, 2026
Earnings
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
Company believes proposed Fortitude merger represents a significant opportunity for the Company’s shareholders; preliminary proxy statement in…
Jun 2, 2026
Press release
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available…
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $5.0K |
| Current FY | — | — | — | $17.1K |
| Next FY | — | — | — | $3.1M |
Short side
FINRA· Sep 30, 20261,131
shares short
-10.3%
vs prior settlement
1.0
days to cover
≈0.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 15, 2026 Earnings
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform
Mar 31, 2026 Inst.
UBS Group AG — DOUBLED
1,086 shares ($71.00)